
    
      This study has a phase I/II design. For this study the administration of panitumumab is
      considered investigational.

      Pretreatment: Part of regular cancer care and disease staging includes Chest/Abdomen CT Scan,
      upper endoscopic ultrasound, PET scan, J-Tube Placement (if clinically indicated),
      bronchoscopy (per clinician judgment), ECG, and baseline laboratory studies.

      During Treatment Weeks 1-5.5 of Radiation Therapy(RT)/Chemotherapy:

        -  RT (180 cGy/fx, Mon-Fri) days 1-5, 8-12, 15-19, 22-26, 29-33 and 36-38.

        -  Panitumumab (per dose level) days 1, 15, 29.

        -  Oxaliplatin (per dose level) days 1, 8, 15, 22, 29, 36.

        -  Capecitabine (per dose level M-F) 1-5, 8-12, 15-19, 22-26, 29-33, 36-38.
    
  